Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
ID: 359274Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is set to re-issue a Notice of Funding Opportunity (NOFO) for the Early-Stage Dissemination and Implementation Research in Communication Disorders, aimed at small businesses. This grant opportunity, utilizing the R21 activity code, focuses on research that seeks to bridge the gap between evidence-based innovations (EBIs) and their adoption in clinical practice and everyday life, specifically in the areas of hearing, balance, taste, smell, voice, speech, and language. With an estimated total program funding of $1,000,000, this initiative encourages collaborative investigations and aims to lay the groundwork for future high-quality R01 applications in the NIDCD mission areas. Interested applicants can reach out to Dr. Holly L. Storkel at holly.storkel@nih.gov or by phone at 301-496-5061 for further information, with the synopsis expected to be posted on August 8, 2025, and applications anticipated to close by October 10, 2025.

    Point(s) of Contact
    Holly L. Storkel, Ph.D. National Institute on Deafness and Other Communication Disorders (NIDCD)
    (301) 496-5061
    holly.storkel@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Loading similar opportunities...